Novartis Pharmaceuticals Director of Engineering Salaries in San Francisco
The average Novartis Pharmaceuticals Director of Engineering in San Francisco earns an estimated $246,913 annually, which includes an estimated base salary of $197,266 with a $49,647 bonus. Novartis Pharmaceuticals' Director of Engineering compensation is $59,536 more than the US average for a Director of Engineering. Director of Engineering salaries at Novartis Pharmaceuticals in San Francisco can range from $150,000 - $473,000.
In San Francisco, The Engineering Department at Novartis Pharmaceuticals earns $17,638 more on average than the HR Department.
Last updated 2 years ago.
- $197,266
- avg. base
- $49,647
- avg. bonus
Director of Engineering Salaries at Novartis Pharmaceuticals
In San Francisco, Directors of Engineering earn $7,522 more than Directors of Engineering.
Compensation at Novartis Pharmaceuticals by Department
In San Francisco, The Engineering Department averages $17,638 more than the HR Department, and $3,891 less than the Communications Department
Director of Engineering Compensation by Gender (All Companies)
The average female Director of Engineering at companies similar size to Novartis Pharmaceuticals reported making $233,006, while the average male Director of Engineering at similar sized companies reported making $235,035.
Director of Engineering Compensation by Ethnicity (All Companies)
The average Asian or Pacific Islander Director of Engineering at companies similar size to Novartis Pharmaceuticals reported making $247,783, while the average Native American Director of Engineering at similar sized companies reported making $150,000.
How Directors of Engineering at Novartis Pharmaceuticals Rate Their Compensation
The majority of Directors of Engineering at Novartis Pharmaceuticals believe they're compensated fairly. 100% of Directors of Engineering at Novartis Pharmaceuticals say they receive annual bonuses, and the vast majority (79%) are satisfied with their benefits. See more compensation ratings at Novartis Pharmaceuticals
